Virus detection and its association with symptoms during influenza-like illness in a sample of healthy adults enrolled in a randomised controlled vaccine trial
Peter F Howard, James M McCaw, Peter C Richmond, Michael Nissen, Theo Sloots, Stephen B Lambert, Michael Lai, Michael Greenberg, Terry Nolan, Jodie McVernon
Influenza and Other Respiratory Viruses | WILEY | Published : 2013
Related Projects (1)
Awarded by Australian Research Council Linkage Project
Awarded by National Health and Medical Research Council (Australia) Career Development Award
MN has received travel grants from Wyeth Australia to present independent research at international meetings, and currently and previously has been the principal investigator for clinical trials sponsored by Abbott, Baxter, CSL, GSK, MedImmune, Merck, Novartis, Sanofi-Pasteur, Wyeth, and Pfizer.We thank study staff at the 12 sites for the recruitment of participants and collection of and processing of samples for this substudy. We thank Dale Cooper (CSL Limited) for facilitating study conduct including provision of study data collected by CSL as part of the main vaccine study. Terry Nolan (Vaccination and Immunisation Research Group, Melbourne, Victoria), Peter Richmond (Telethon Institute for Child Health Research, Perth, Western Australia), Jeff Karrasch (Australian Clinical Research Organisation, four sites across Queensland NSW), Helen Marshall (Adelaide Women's and Children's Hospital, Adelaide, South Australia), Sepehr Shakib (CMAX, Adelaide, South Australia), Fred de Looze (Queensland Trialworks, Queensland), John McBride (James Cook University, Cairns, Queensland), Maree O'Sullivan (Hobart Sexual Health Service, Hobart, Tasmania) and Walter Abhayaratna (Australian National University, Canberra, Australian Capital Territory) led the investigation at participating sites. We thank Dr Julie Simpson for statistical advice. This research was supported by an Australian Research Council Linkage Project (LP0989464) with support from CSL Limited, Victoria, Australia. Jodie McVernon is supported by a National Health and Medical Research Council (Australia) Career Development Award (566635).